eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

How to?

Mobic vs Voltaren, a side effect and effectiveness comparison for a female patient aged 63

This is personalized comparison of Mobic vs Voltaren for a female aged 63. The study is created by eHealthMe based on reports from FDA and social media.

Get a free personalized report of your drugs: we study for you 352 million drug outcomes from FDA and social media. Start to use eHealthMe >>>

What are the drugs

Mobic (latest outcomes from 12,468 users) has active ingredients of meloxicam. It is often used in arthritis.

Voltaren (latest outcomes from 20,076 users) has active ingredients of diclofenac sodium. It is often used in arthritis.

On May, 12, 2014: 6,066 female patients aged 59 who take the same drugs are studied in Mobic vs Voltaren

Information of patient in study:

GenderAgeReason for the drug
Female59Inflammation

Drugs to compare:

DrugIngredientsCompany
Mobic meloxicamnot specified
Voltaren diclofenac sodiumnot specified

eHealthMe real world results:

For females aged 59 (±5):

Most common side effects:

(click on each outcome to view in-depth analysis, incl. how people recovered)
MobicVoltaren
Nausea (feeling of having an urge to vomit)Pyrexia (fever)
PainNausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)Vomiting
Pyrexia (fever)Malaise (a feeling of general discomfort or uneasiness)
Arthralgia (joint pain)Dyspnoea (difficult or laboured respiration)
Anaemia (lack of blood)Pain
DiarrhoeaArthralgia (joint pain)
Pain In ExtremityDiarrhoea
Dyspnoea (difficult or laboured respiration)Fatigue (feeling of tiredness)
Oedema Peripheral (superficial swelling)Alanine Aminotransferase Increased

Most common side effects experienced by people in long term use:

(click on each outcome to view in-depth analysis, incl. how people recovered)
MobicVoltaren
Lung Neoplasm (tumour of lung)Blood Alkaline Phosphatase Increased
Asthenia (weakness)Blood Bilirubin Increased
Weight DecreasedGamma-glutamyltransferase Increased
PneumoniaRestlessness (not able to rest)
Fatigue (feeling of tiredness)Alanine Aminotransferase Increased
Nausea (feeling of having an urge to vomit)Blood Albumin Increased
Abdominal Pain UpperHyperkalaemia (damage to or disease of the kidney)
Candidiasis (candidiasis or thrush is a fungal infection)Depression
Parotid SwellingMuscle Necrosis (muscle cell damage)
Urticaria (rash of round, red welts on the skin that itch intensely)Renal Failure Acute (rapid kidney dysfunction)

Drug effectiveness:

not at allsomewhatmoderatehighvery high
Mobic4.62%26.05%32.77%30.67%5.88%
Voltaren0.00%31.93%28.57%31.93%7.56%

How to use the study:
1. print a copy of the study
and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
2. start a mobile support group with people like you or your health teams to improve treatment outcomes together.

Next: study your drugs OR ask a question from Patients Like You

Drug effectiveness in real world:

Alternative drugs:

Side effects in real world:

On eHealthMe, Mobic (meloxicam) is often used to treat arthritis. Voltaren (diclofenac sodium) is often used to treat arthritis. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

Recent related drug comparison:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

38 million health professionals and patients have studied on eHealthMe. Recent studies:

- Candesartan Cilexetil for a 61-year old man who has H ... (10 minutes ago)

- Iron Dextran, Vitamin B12, Zoloft for a 38-year old w ... (15 minutes ago)

- Crestor for a 53-year old woman who has Neuropathy (35 minutes ago)

Related studies

- Mobic side effects
- Voltaren side effects

 

Related conditions

- Inflammation

 

 

Recent user comments

- "My muscle tone started diminishing, had changes in sk ... " (37 minutes ago)

- "my mother has been taking atenolol and has recently b ... " (2 hours ago)

- "Low dosage and first one pill. Toke it at morning, na ... " (3 hours ago)

 

Recent mobile support groups

- Histamine Intolerance

- Inhame-bravo and Chinese Goldenseal

- Lamivudine and Acyclovir

- Lexapro and Bradycardia Neonatal

- Indian Chocolate and Parsidol

 

Popular searches

- Kale
- Gnathoschisis
- Obstruction Of The Ureteropelvic Junction
- Flexeril
- Suffocation Feeling

   

Drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Side effects: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Symptoms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.